Gonadotropin-releasing hormone (GnRH) stimulated the formation of two major metabolites of the 5-lipoxygenase pathway, leukotriene (LT) B4 and LTC4, as well as luteinizing hormone (LH) release in primary cultures of rat anterior pituitary cells. Several lines of evidence suggested the presence of a GnRH-dependent pituitary endocrine system in which LTs act as second messengers for LH release: (i) GnRH-dependent LT formation was observed within 1 min and immediately preceded GnRH-induced LH release, whereas exogenous LTs stimulated LH release at low concentrations; (i) the dose responses of GnRH-induced LT production and LH release were similar and both effects required the presence of extracellular Ca2+ ions; (ii) GnRH-induced LH release was blocked by up to 45% following the administration of several LT receptor antagonists; (iv) LTE4 action on LH secretion was entirely abolished by LT receptor antagonists; and (v) Gonadotropin-releasing hormone (GnRH), a decapeptide that is formed in the hypothalamus, stimulates the synthesis and secretion of gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone, in a small subset of pituitary cells (1, 2). Besides its established physiological role in the control of gonadotropin release, GnRH and its analogues administered exogenously are used to treat patients afflicted with infertility and estrogen-dependent diseases. In recent years attempts have been made to elucidate the mechanisms of action of GnRH, and it has been shown that GnRH activates a phosphatidylinositol 4,5-bisphosphate-specific phospholipase C (3). This reaction generates diacylglycerol, the endogenous activator of protein kinase C (4, 5), and inositol 1,4,5-trisphosphate, which induces a rise in the concentration of intracellular free Ca2+ ions (6). The GnRHdependent activation of LH secretion is accompanied by arachidonic acid (AA) release from cellular phospholipids (7). Moreover, exogenous leukotrienes (LTs) at picomolar concentrations have been shown to induce LH release in primary cultures of rat anterior pituitary cells (8, 9).
Gonadotropin-releasing hormone (GnRH), a decapeptide that is formed in the hypothalamus, stimulates the synthesis and secretion of gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone, in a small subset of pituitary cells (1, 2) . Besides its established physiological role in the control of gonadotropin release, GnRH and its analogues administered exogenously are used to treat patients afflicted with infertility and estrogen-dependent diseases. In recent years attempts have been made to elucidate the mechanisms of action of GnRH, and it has been shown that GnRH activates a phosphatidylinositol 4,5-bisphosphate-specific phospholipase C (3). This reaction generates diacylglycerol, the endogenous activator of protein kinase C (4, 5) , and inositol 1,4,5-trisphosphate, which induces a rise in the concentration of intracellular free Ca2+ ions (6) . The GnRHdependent activation of LH secretion is accompanied by arachidonic acid (AA) release from cellular phospholipids (7) . Moreover, exogenous leukotrienes (LTs) at picomolar concentrations have been shown to induce LH release in primary cultures of rat anterior pituitary cells (8, 9) .
The second-messenger role of AA release in the mechanism of action of GnRH remains to be defined. Rat anterior pituitary cells mainly metabolize free AA by oxidative pathways (10) , and GnRH-stimulated release of LH can be attenuated by inhibition of 5-lipoxygenase (11) . Therefore, it has been proposed that LTs and possibly other oxygenated products of AA metabolism are physiological mediators of LH release and other brain functions (8, 12, 13) . Although no evidence has been presented that pituitary cells express the 5-lipoxygenase pathway, Lindgren et al. (14) reported that several brain tissues, including the hypothalamus, can form LTs. However, the source of LTs in the anterior pituitary, their functional role, and whether LTs can act as second messengers in the signaling pathway of GnRH remain unanswered questions. In the work detailed below we used monolayer cultures and a superfusion system of primary anterior pituitary cells in an attempt to elucidate the role of LTs in pituitary cell function. Our results demonstrate that pituitary cells form LTB4 and LTC4 in response to GnRH and provide strong support for the hypothesis that LTs act as second messengers in the GnRH signaling pathway.
MATERIALS AND METHODS
Cell Culture. Single-cell suspensions were prepared from anterior pituitary glands ofadult female Sprague-Dawley rats (200 g; Savo-Ivanowas, Kisslegg, F.R.G.) as described (15) . Cells were maintained on Cytodex beads (Pharmacia) at a cell/bead ratio of 20:1 in Earle's medium 199 (Biochrom, Berlin) supplemented with 60 pug of gentamicin per ml and 10o horse serum. Superfusion experiments were performed using perifusion columns (Pharmacia) with 2 x 107 cells per column. The superfusion medium was supplemented with 20 mM Hepes and the flow rate was 0.5 ml/min. Downregulation of GnRH receptors was accomplished by incubation of pituitary cells in the presence of the GnRH agonist buserelin [pyroGlu-His-Trp-Ser-Tyr-D-Ser(t-Bu)-Leu-ArgPro-NHEt] at 0.1 ,uM for 24 hr as described (16 (20) . The RP-HPLC system was equipped with an M-510 pump and a single-wavelength UV detector operating at 280 nm (Waters). LTs were eluted isocratically at a flow rate of 1 ml/min. The retention times of LTC4 and LTB4 were 23 and 35 min, respectively. Concentrations of LTC4 and LTB4 were determined by RIA (21) . Fractions containing LTC4 and LTB4, respectively, were collected, dried under nitrogen, and taken up in RIA buffer (10 mM KH2PO4/10 mM Na2HPO4/150 mM NaCl, pH 7.4).
Water samples subjected to exactly the same analytical procedure as the biological samples ranged between 8 mined subsequent LT formation as well as LH release. We found that GnRH strongly stimulated LT production at similar concentrations as were required for LH release (Table  2 and see below) . Furthermore, the magnitude of GnRHdependent LT synthesis was almost identical to that of Ca2l ionophore-dependent LT synthesis, which we consider to represent the total 5-lipoxygenase pathway activity of all pituitary cells.
In the second type of experiment, GnRH receptor desensitization was used to determine the relation between expression of GnRH receptors and LT synthesis in the total anterior pituitary cell population. The GnRH agonist buserelin was used to specifically desensitize GnRH receptors (16 Kinetics of GnRH-Dependent LT Synthesis and Concentration Dependence of LT-Induced LH Release in Anterior Pituitary Cells. To study the relation between the effects ofGnRH on LT formation and LH release in more detail, we determined the kinetics and concentration dependence of both effects. We found that GnRH-induced LH release and LTC4 and LTB4 synthesis paralleled each other in a time-and concentration-dependent manner. LTC4 dramatically induced LH release, amounting to a 7-fold increase within 10 min (Fig. 1) . The same type of experiments have been carried out using the GnRH superagonist buserelin (results not shown). Buserelin mimicks the effect of GnRH on LT formation in anterior pituitary cells and is more potent in its action on LT synthesis than GnRH. Furthermore, LTB4 and to a lesser extent LTA4 and LTE4 were also strong inducers of LH release (Fig. 2) . These results confirmed and extended published data by Hulting et al. (8) anterior pituitary cells were prepared and 1 nM GnRH or 30 pM LTC4 was added at the indicated times. The superfusion medium containing 1.5 mM Ca2+ was changed to Ca2+-free medium at 130 min (A) or from Ca2+-free to Ca2+-containing medium at 110 min (B).
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potent inducers of LH release in the pituitary might be explained by the use of the superfusion system employed in these types of experiments (see Fig. 2 ). In contrast to the maintenance of cells in culture dishes, this system allows continuous monitoring of LH release in response to repetitive additions of different agonists or culture media under standardized conditions and thus provides the opportunity to detect relatively small changes in the concentration of LH in the perifusion medium. The Effects of GnRH and Exogenous LTC4 on LH Release Require Extracellular Ca2+, and LT-Dependent LH Release Is Synergistically Enhanced by Phorbol Ester. To further study the relation between GnRH-dependent and LT-dependent LH release, we examined the effects of phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C, on LH release in the presence or absence of LTE4. PMA at 0.1 nM Proc. Nat!. Acad. Sci. USA 88 (1991) or LTE4 at 1 pM had no effect on LH release. However, when PMA and LTE4 were added together, significant LH release was observed (Fig. 3) . This raises the possibility that GnRH and LTE4 share a common metabolic pathway in the LH release reaction. Further evidence for this possibility was provided by the striking Ca2+ dependence ofboth GnRH-and LTC4-dependent LH release (Fig. 4) .
Several LT Receptor Antagonists Inhibit the Effects of GnRH and LTE4 on LH Release. To study whether LTs can act as second messengers for the GnRH signaling pathway, anterior pituitary cells were preincubated in the presence of LT receptor antagonists before addition ofGnRH. All three LT receptor antagonists significantly inhibited the effect of GnRH on LH release in superfused rat anterior pituitary cells (Fig. 5) 
DISCUSSION
Our results can be summarized as follows: rat anterior pituitary cells possess a functional 5-lipoxygenase pathway, and gonadotrophs are the major source of LT formation in this tissue. GnRH and its analogue buserelin stimulate LT formation and LH release, and both effects depend on extracellular Ca2+ ions and require similar concentrations of agonist (24) . In addition, GnRH-dependent LT release precedes LH release, and LT receptor antagonists significantly block the effect of GnRH on LH release. Exogenously administered LTs, at picomolar concentrations, induce LH release, and the effect of submaximal concentrations of LTs on LH release is synergistically enhanced by an activator of protein kinase C. When considered together these results provide strong support for the hypothesis, originally proposed by Hulting et al. (8, 12) , that LTs are involved in the control of LH release in the pituitary. In particular, we have identified GnRH receptor-expressing cells as the major source of LT synthesis in the anterior pituitary and provided an experimental framework for the further study of the role of LTs in endocrine tissues.
The conclusion that cells that express GnRH receptors are a major source of LT synthesis in the pituitary is based on two types of experiments. First, the magnitude of GnRHdependent LT formation is almost identical with receptorindependent (i.e., Ca2+ ionophore-dependent) LT formation (Table 1) . Second, that GnRH receptor-desensitized cells showed a >95% inhibition of LT synthesis in response to Ca2+ ionophore indicates that expression of the 5-lipoxygenase pathway in the pituitary is largely confined to a small subpopulation of pituitary cells, namely, those that express GnRH receptors. Further studies are required to elucidate the mechanism and functional significance of GnRHdependent down-regulation of the 5-lipoxygenase pathway.
While it is very difficult to prove that LTs function as second messengers in the GnRH signaling pathway, several lines of evidence strongly support such a role: (i) the potency of LTC4 induction of LH release is several orders of magnitude higher than that of its physiological agonist, GnRH (Fig.  4) ; (ii) the kinetics of GnRH-dependent LT synthesis are consistent with a second-messenger role in the LH release pathway; and (iii) most important, several LT receptor antagonists are capable of significantly blocking the effect of GnRH on LH release.
LTs are believed to act in an autocrine and/or paracrine fashion in vivo (25) , and our LT receptor antagonist data are compatible with this hypothesis. AA and LTs may act together with other second-messenger pathways, such as phospholipase C and protein kinase C (3, 4, 5, 26), since LT receptor antagonists only partially block the effect of GnRH on LH release and since activators of protein kinase C act synergistically with LTE4 to induce LH release (Fig. 3) . The signaling pathways induced by GnRH may, however, also synergize with those induced by LTE4, since data from others demonstrated an activation of protein kinase C by LTs (27) .
